Scilex Holding Co. (SCLX)
4.89
-0.05
(-1.01%)
USD |
NASDAQ |
Sep 25, 16:00
4.89
0.00 (0.00%)
After-Hours: 19:59
Scilex Research and Development Expense (Annual) : 20.71M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 20.71M |
| December 31, 2024 | 9.641M |
| December 31, 2023 | 12.75M |
| Date | Value |
|---|---|
| December 31, 2022 | 9.054M |
| December 31, 2021 | 9.201M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Semnur Pharmaceuticals, Inc. | 2.546M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |
| Johnson & Johnson | 14.83B |